Thomas Andrew Crockett Kal Vista Pharmaceuticals, Inc. (KALV) insider trading activity
Thomas Andrew Crockett is CEO of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 211,203 shares of KALV, which is worth approximately $2.17 Million. The most recent transaction as insider was on Jun 09, 2021, when has been sold 8,933 shares (Common Stock) at a price of $30.05 per share, resulting in proceeds of $268,437. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
211K
0%
3M change
52.21%
12M change
Total Value Held
$2.17 Million
Thomas Andrew Crockett Transaction History
TAC
Thomas Andrew Crockett
CEO
Cambridge, MA